Likely active: new fund Jan 2024 Verified 7 Nov 2026
VIVES
Seed and early-stage deep tech venture fund initiated by UCLouvain that backs university spin-offs and technology startups in biotech, pharma, medtech, engineering/IT and agri, through funds including the VIVES Inter-University Fund.
- Type
- VC firm
- Location
- Louvain-la-Neuve, Belgium
- Stages
- Seed, Series A, Series B
- Sectors
- Deep tech, Biotech, Healthtech and life sciences, Medtech, Agritech
- Fund size / AUM
- VIVES Inter-University Fund EUR 70M after second closing (own site)
- Latest fund or filing
- 30 Jan 2024
- Website
- www.vivesfund.com/fr
Contacts on file
For VIVES, the paid file holds: 4 named decision-makers with roles; firm contact email (domain checked); LinkedIn page.
Get Europe Complete, $99 Free sample
One-time payment. No subscription. No account.
Notable investments
NuclidiumBionyra PharmaEligo BioscienceNovadipLMO Space
Sources
- www.vivesfund.com/fr
- www.vivesfund.com/fr/equipe
- www.vivesfund.com/fr/entreprise
- www.vivesfund.com/fr/news
- www.vivesfund.com/fr/news/vives-inter-university-fund-boucle-son-second-tour-70-
- lpea.lu/membership/members-list/
Last checked 7 Nov 2026. Is something wrong? Tell us.
Appears in 33 lists
Series B agritech investors (24)Medtech investors in Europe (45)Series B medtech investors (57)Agritech investors in Europe (63)Series A agritech investors (65)Series B biotech investors (73)Biotech investors in Europe (89)Seed agritech investors (97)Series B deep tech investors (113)Series B investors in Europe (117)Series A medtech investors (125)Agritech investors (137)Series A biotech investors (153)Series B healthtech investors (160)Seed medtech investors (278)Healthtech investors in Europe (291)Series A deep tech investors (293)Deep tech investors in Europe (299)Seed biotech investors (300)Series A investors in Europe (329)Series B investors (339)Series A healthtech investors (401)Venture capital firms in Europe (412)Medtech investors (457)Biotech investors (484)Seed investors in Europe (543)Seed deep tech investors (555)Startup investors in Europe (725)Deep tech investors (763)Seed healthtech investors (800)Series A investors (864)Healthtech investors (1,207)Seed investors (1,892)